Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells
Open Access
- 17 June 2013
- journal article
- research article
- Published by Springer Nature in BMC Veterinary Research
- Vol. 9 (1) , 119
Abstract
Background: In both women and female dogs, the most prevalent type of malignant neoplasm is the spontaneous mammary tumor. In dogs, half of these are malignant. The treatment of choice for the canine patients is surgical mastectomy. Unfortunately, it often fails in high-risk, locally invasive mammary tumors as of during the time of the surgery the micro-metastases are present. Moreover, there are neither large studies conducting to prove of the benefit from the chemotherapy in dogs nor established chemotherapy treatment protocols available. Additionally, the effectiveness of each individual chemotherapeutic agent and drug resistance of canine mammary cancer have not yet been characterized. That has become the aim of our study, to assess the expression of PGP, BCRP, MRP1 and MRP3 in canine mammary cancer cell lines and to investigate their role in cancer resistance to vinblastine, cisplatin and cyclophosphamide with using RNAi approach. Results: The results suggested that in canine mammary cancer, the vinblastine efflux was mediated by PGP and MRP1 proteins, cisplatin efflux was mediated by all four examined efflux pumps (PGP, BCRP, MRP1 and MRP3), whereas cyclophosphamide resistance was related to BCRP activity. RNAi silencing of these efflux pumps significantly decreased IC50 doses of the examined drugs in canine mammary carcinoma cells. Conclusions: Our results have indicated the treatment of cells involving use of the siRNA targeting efflux pumps could be a beneficial approach in the future.Keywords
This publication has 29 references indexed in Scilit:
- CSF-1R as an inhibitor of apoptosis and promoter of proliferation, migration and invasion of canine mammary cancer cellsBMC Veterinary Research, 2013
- A role of ghrelin in canine mammary carcinoma cells proliferation, apoptosis and migrationBMC Veterinary Research, 2012
- Global gene expression profiles of canine macrophages and canine mammary cancer cells grown as a co-culture in vitroBMC Veterinary Research, 2012
- Transcriptomic signature of cell lines isolated from canine mammary adenocarcinoma metastases to lungsJournal of Applied Genetics, 2010
- Expression of ABC‐Transport Proteins in Canine Mammary Cancer: Consequences for ChemotherapyReproduction in Domestic Animals, 2009
- Knocking down barriers: advances in siRNA deliveryNature Reviews Drug Discovery, 2009
- Analyzing real-time PCR data by the comparative CT methodNature Protocols, 2008
- Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogsVeterinary and Comparative Oncology, 2008
- Mammary Tumor Recurrence in Bitches After Regional MastectomyVeterinary Surgery, 2008
- Selection of Reference Genes for Quantitative Real-time PCR Analysis in Canine Mammary Tumors Using the GeNorm AlgorithmVeterinary Pathology, 2006